Janus Henderson Group’s Novavax NVAX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$496K Hold
60,815
﹤0.01% 2009
2025
Q4
$409K Hold
60,815
﹤0.01% 2093
2025
Q3
$527K Hold
60,815
﹤0.01% 1977
2025
Q2
$383K Hold
60,815
﹤0.01% 2076
2025
Q1
$425K Hold
60,815
﹤0.01% 2040
2024
Q4
$489K Hold
60,815
﹤0.01% 2049
2024
Q3
$768K Hold
60,815
﹤0.01% 1797
2024
Q2
$770K Buy
60,815
+24,620
+68% +$248K ﹤0.01% 1759
2024
Q1
$172K Buy
36,195
+129
+0.4% +$598 ﹤0.01% 2451
2023
Q4
$173K Sell
36,066
-109
-0.3% -$667 ﹤0.01% 2465
2023
Q3
$262K Buy
36,175
+62
+0.2% +$495 ﹤0.01% 2255
2023
Q2
$268K Sell
36,113
-50
-0.1% -$393 ﹤0.01% 2312
2023
Q1
$253K Buy
36,163
+20,496
+131% +$189K ﹤0.01% 2370
2022
Q4
$161K Sell
15,667
-15,669
-50% -$277K ﹤0.01% 2235
2022
Q3
$572K Buy
31,336
+16,015
+105% +$694K ﹤0.01% 1894
2022
Q2
$788K Buy
15,321
+7,956
+108% +$412K ﹤0.01% 1467
2022
Q1
$542K Buy
+7,365
New +$657K ﹤0.01% 1859
2021
Q4
Sell
-7,044
Closed -$1.46M 2574
2021
Q3
$1.46M Sell
7,044
-1,041
-13% -$229K ﹤0.01% 1309
2021
Q2
$1.72M Buy
+8,085
New +$1.48M ﹤0.01% 1261

Other funds holding NVAX

Janus Henderson Group's NVAX Position: Q1 2026 in Review

Janus Henderson Group held its Novavax (NVAX) position steady in Q1 2026 at 60,815 shares worth $496K. The position accounts for ﹤0.01% of the portfolio, ranked #2009.

Janus Henderson Group first reported a position in NVAX in Q2 2021 and has held it in 19 quarters since. The position peaked at $1.72M in Q2 2021. 257 funds tracked by Wall St. Rank hold NVAX as of Q1 2026.

  • Janus Henderson Group held 60,815 shares of Novavax worth $496K as of Q1 2026.
  • Janus Henderson Group left its Novavax share count unchanged in Q1 2026.
  • Novavax made up ﹤0.01% of Janus Henderson Group's portfolio in Q1 2026, its #2009 holding.
  • Janus Henderson Group first reported a position in Novavax in Q2 2021 and has held it in 19 quarters since.
  • Janus Henderson Group's Novavax position peaked at $1.72M in Q2 2021.
  • 257 funds tracked by Wall St. Rank held Novavax as of Q1 2026.

Based on Janus Henderson Group's 13F filing for Q1 2026, filed 15 May 2026.